Google News EN
HLB Co., Ltd. Revenue Breakdown – KRX:028300 - TradingView
07/25/2026, 21:09 GMT+9
Google News EN
HLB Unit Immunomic Doses First Patient in U.S. Phase 1 Cancer Vaccine Trial - Seoul Economic Daily
07/20/2026, 09:33 GMT+9
Google News EN
HLB Shakes Off 'Limit-Down Nightmare' as 8 Group Stocks Hit Ceiling - Seoul Economic Daily
07/15/2026, 16:00 GMT+9
Google News EN
HLB Secures FDA Inspection Findings, Formally Launches Re-application for Liver Cancer Drug - finance.biggo.com
07/14/2026, 00:36 GMT+9
Google News EN Broad
As HLB's stock price plunged due to unfavorable factors related to new drugs, the market capitalizat.. - 매일경제
07/13/2026, 16:00 GMT+9
Google News EN Broad
HLB group stocks sink in South Korea after FDA rejects liver cancer drug - CHOSUNBIZ - Chosunbiz
07/10/2026, 16:00 GMT+9
Google News EN
HLB Plunges to Daily Limit as FDA Issues Third Rejection for Liver Cancer Drug; Group Stocks Wiped Out - finance.biggo.com
07/09/2026, 16:00 GMT+9
Google News EN Broad
BlackRock takes 5% stake in HLB amid FDA review - The Korea Herald
03/04/2026, 17:00 GMT+9
Google News EN
HLB Names Kim Dong-geon as New Elevar CEO to Lead Commercialization - Seoul Economic Daily
01/29/2026, 17:00 GMT+9
Google News EN
HLB Co., Ltd. (028300.KQ) stock price, news, quote and history - Yahoo Finance Australia
08/15/2017, 22:56 GMT+9